NO943353L - Kombinasjoner av ACE-inhibitorer og diuretiske midler - Google Patents

Kombinasjoner av ACE-inhibitorer og diuretiske midler

Info

Publication number
NO943353L
NO943353L NO943353A NO943353A NO943353L NO 943353 L NO943353 L NO 943353L NO 943353 A NO943353 A NO 943353A NO 943353 A NO943353 A NO 943353A NO 943353 L NO943353 L NO 943353L
Authority
NO
Norway
Prior art keywords
diuretics
combinations
ace inhibitors
ace
inhibitors
Prior art date
Application number
NO943353A
Other languages
English (en)
Other versions
NO943353D0 (no
NO306931B1 (no
Inventor
J Krister Kristianson
Per Wold-Olsen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO943353D0 publication Critical patent/NO943353D0/no
Publication of NO943353L publication Critical patent/NO943353L/no
Publication of NO306931B1 publication Critical patent/NO306931B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO943353A 1992-03-11 1994-09-09 Farmasoeytisk formulering av ACE-inhibitor og diuretisk middel NO306931B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84955492A 1992-03-11 1992-03-11
PCT/US1993/001813 WO1993017685A1 (en) 1992-03-11 1993-03-02 Combinations of ace inhibitors and diuretics

Publications (3)

Publication Number Publication Date
NO943353D0 NO943353D0 (no) 1994-09-09
NO943353L true NO943353L (no) 1994-09-09
NO306931B1 NO306931B1 (no) 2000-01-17

Family

ID=25305985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943353A NO306931B1 (no) 1992-03-11 1994-09-09 Farmasoeytisk formulering av ACE-inhibitor og diuretisk middel

Country Status (11)

Country Link
US (1) US5686451A (no)
EP (1) EP0643580A4 (no)
JP (1) JPH07504659A (no)
AU (1) AU686097B2 (no)
CA (1) CA2130577C (no)
DK (1) DK9200258U4 (no)
ES (1) ES2083931T1 (no)
NO (1) NO306931B1 (no)
NZ (1) NZ249773A (no)
WO (1) WO1993017685A1 (no)
ZA (1) ZA931714B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
GB2318057B (en) * 1995-08-02 1999-09-22 Oxford Health Management Ltd Treatment of nocturnal polyuria and medicaments therefor
GB9515826D0 (en) * 1995-08-02 1995-10-04 Oxford Health Management Ltd Treatment of nocturnal polyuria and medicaments therefor
SE9600120D0 (sv) * 1996-01-15 1996-01-15 Astra Ab Novel medical use
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
GB2361185A (en) 2000-04-10 2001-10-17 Nicholas J Wald Pharmaceutical formulation for the prevention of cardiovascular disease
WO2001080895A2 (en) * 2000-04-26 2001-11-01 First Horizon Pharmaceutical Corporation Methods and compositions for the treatment of cardiac indications
US7226474B2 (en) * 2000-05-01 2007-06-05 Endovascular Technologies, Inc. Modular graft component junctions
US7666221B2 (en) * 2000-05-01 2010-02-23 Endovascular Technologies, Inc. Lock modular graft component junctions
JP2004517804A (ja) * 2000-06-28 2004-06-17 メルク・アンド・カンパニー・インコーポレーテッド 心臓血管病の治療法
WO2003013434A2 (en) * 2001-08-06 2003-02-20 Genomed, Llc Methods and compositions for treating diseases associated with excesses in ace
US20050203169A1 (en) * 2001-08-06 2005-09-15 Moskowitz David W. Methods and compositions for treating diseases associated with excesses in ACE
US7708771B2 (en) 2002-02-26 2010-05-04 Endovascular Technologies, Inc. Endovascular graft device and methods for attaching components thereof
US8211166B2 (en) * 2002-02-26 2012-07-03 Endovascular Technologies, Inc. Endovascular grafting device
US7942924B1 (en) 2002-03-04 2011-05-17 Endovascular Technologies, Inc. Staged endovascular graft delivery system
DK1635792T3 (da) * 2003-06-26 2009-06-15 Teva Pharma Stabile farmaceutiske sammensætninger af 2-aza-bicyklo-3.3.0-oktan-3-carboxylsyrederivater
EA011862B1 (ru) * 2004-03-24 2009-06-30 Актавис Груп Хф. Композиции рамиприла
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
JP2009533461A (ja) * 2006-04-19 2009-09-17 テバ ファーマシューティカル インダストリーズ リミティド ２−アザ−ビシクロ［３．３．０］−オクタン−３−カルボン酸誘導体の安定な医薬組成物
CN101478983A (zh) * 2006-07-10 2009-07-08 特瓦制药工业有限公司 含有对水分敏感的药物和第二药物的组合的稳定制剂及其制造方法
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1120400A (en) * 1977-12-27 1982-03-23 Zola P. Horovitz Method of treating hypertension and medicaments therefor
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
US5256687A (en) * 1985-09-09 1993-10-26 Hoechst Aktiengesellschaft Pharmaceutical composition for the treatment of high blood pressure
SE506179C2 (sv) * 1989-01-23 1997-11-17 Ciba Geigy Ag Farmaceutisk lågkomposition av benazepril och ett tiaziddiuretikum
ATE122228T1 (de) * 1991-07-01 1995-05-15 Gergely Gerhard Verfahren zur herstellung einer pharmazeutischen zubereitung mit wenigstens zwei verschiedenen wirkstoffen und verwendung einer solchen zubereitung.

Also Published As

Publication number Publication date
CA2130577A1 (en) 1993-09-16
WO1993017685A1 (en) 1993-09-16
EP0643580A1 (en) 1995-03-22
US5686451A (en) 1997-11-11
CA2130577C (en) 2003-09-16
ES2083931T1 (es) 1996-05-01
DK9200258U4 (da) 1993-07-23
ZA931714B (en) 1993-09-30
NO943353D0 (no) 1994-09-09
JPH07504659A (ja) 1995-05-25
AU686097B2 (en) 1998-02-05
NZ249773A (en) 1996-01-26
NO306931B1 (no) 2000-01-17
AU3736093A (en) 1993-10-05
EP0643580A4 (en) 1995-04-19

Similar Documents

Publication Publication Date Title
NO943353L (no) Kombinasjoner av ACE-inhibitorer og diuretiske midler
NO930044L (no) Fremgangsmaate til vurdering av formasjoner og borkronetilstander
NO933131D0 (no) Fremgangsmaate og anordning for deteksjon av eksplosiver
NO180145C (no) Tannbörste og tildannelse av samme
NO930194D0 (no) Fremgangsmaate og anordning for mikromoenstringer av overflater
DK543189A (da) Lysyloxidaseinhibitorer og deres anvendelse
FI953954A (fi) HIV:n käänteistranskriptaasin inhibiittoreita
NO165494C (no) Aminosalter av lignosulfonater og anvendelse derav.
NO169052C (no) Hydraulisk hammer og anvendelse av samme
NO931400D0 (no) Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav
NO940190D0 (no) Anvendelse av x-ketoglutarat
IS1813B (is) Notkun á ferróseni og/eða ferrósenafleiðum
NO883927L (no) Staal og anvendelse av dette.
NO931399D0 (no) Anvendelse av naturstein
FI1031U1 (fi) En troakar
TR23973A (tr) Feniltio uereler fenilnoti uereler ve fenil karbodi- imidler bunlarin elde edilmeleri
NO932160D0 (no) Fremgangsmaate for deteksjon av cathepsin g og alfa-1-antichymotrypsin komplekser
NO953272D0 (no) Kombinasjoner av retrovirale inhibitorer
NO950778D0 (no) Kloning og ekspresjon av
DE69320583T2 (de) Nachweis von Antibiotika
NO930795D0 (no) Fremgangsmaate og elementsett til bruk ved ettertrekking av eternittak
KR930026760U (ko) Tvcr의 개선된 구성
NO920025L (no) Synergime av hiv-reverstranskriptaseinhibitorer
FI93532C (fi) Metallilevystä valmistettu vene
NO932164D0 (no) Paraseilsystem for fremdrift og manoevrering av fartoeyer

Legal Events

Date Code Title Description
MK1K Patent expired